KRAS codon 12 and 13 wild-type metastatic colorectal cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 40238, "infons": {"fpage": "1667", "pub-id_pmid": "19033564", "section_type": "REF", "source": "J Natl Cancer Inst", "type": "ref", "volume": "100", "year": "2008"}, "text": "K-Ras mutations are changingpractice in advanced colorectal cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 40305, "infons": {"fpage": "219", "pub-id_pmid": "12110640", "section_type": "REF", "source": "Jpn J Clin Oncol", "type": "ref", "volume": "32", "year": "2002"}, "text": "Concurrent mutations of K-ras oncogene at codons 12 and 22 in colon cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 40380, "infons": {"fpage": "75", "pub-id_pmid": "2017878", "section_type": "REF", "source": "Virus Genes", "type": "ref", "volume": "5", "year": "1991"}, "text": "A novel point mutation at codon 146 of the K-ras gene in a human colorectal cancer identified by the polymerase chain reaction", "sentences": [], "annotations": [], "relations": []}, {"offset": 40507, "infons": {"fpage": "842", "pub-id_pmid": "8157709", "section_type": "REF", "source": "J Clin Endocrinol Metab", "type": "ref", "volume": "78", "year": "1994"}, "text": "H-ras mutations in human pituitary carcinoma metastases", "sentences": [], "annotations": [], "relations": []}, {"offset": 40563, "infons": {"fpage": "S52", "pub-id_pmid": "19064407", "section_type": "REF", "source": "Clin Colorectal Cancer", "type": "ref", "volume": "7", "year": "2008"}, "text": "Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 40683, "infons": {"fpage": "405", "pub-id_pmid": "2403644", "section_type": "REF", "source": "Mol Cell Biol", "type": "ref", "volume": "10", "year": "1990"}, "text": "Neutron radiation can activate K-ras via a point mutation in codon 146 and induces a different spectrum of ras mutations than does gamma radiation", "sentences": [], "annotations": [], "relations": []}, {"offset": 40830, "infons": {"fpage": "9433", "pub-id_pmid": "12093899", "section_type": "REF", "source": "Proc Natl Acad Sci USA", "type": "ref", "volume": "99", "year": "2002"}, "text": "Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 40921, "infons": {"fpage": "1749", "pub-id_pmid": "19075190", "section_type": "REF", "source": "Blood", "type": "ref", "volume": "113", "year": "2009"}, "text": "High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients", "sentences": [], "annotations": [], "relations": []}, {"offset": 41026, "infons": {"fpage": "1408", "pub-id_pmid": "19339720", "section_type": "REF", "source": "N Engl J Med", "type": "ref", "volume": "360", "year": "2009"}, "text": "Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 41107, "infons": {"fpage": "1", "pub-id_pmid": "19102707", "section_type": "REF", "source": "Pharmacogenomics", "type": "ref", "volume": "10", "year": "2009"}, "text": "Setting future standards for KRAS testing in colorectal cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 41170, "infons": {"fpage": "525", "pub-id_pmid": "2841597", "section_type": "REF", "source": "N Engl J Med", "type": "ref", "volume": "319", "year": "1988"}, "text": "Genetic alterations during colorectal-tumor development", "sentences": [], "annotations": [], "relations": []}, {"offset": 41226, "infons": {"fpage": "855", "pub-id_pmid": "15035987", "section_type": "REF", "source": "Cell", "type": "ref", "volume": "116", "year": "2004"}, "text": "Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF", "sentences": [], "annotations": [], "relations": []}, {"offset": 41315, "infons": {"fpage": "33085", "pub-id_pmid": "15159408", "section_type": "REF", "source": "J Biol Chem", "type": "ref", "volume": "279", "year": "2004"}, "text": "Mitogen-activated protein kinase phosphatase-3 is a tumor promoter target in initiated cells that express oncogenic Ras", "sentences": [], "annotations": [], "relations": []}, {"offset": 41435, "infons": {"fpage": "875", "pub-id_pmid": "15520807", "section_type": "REF", "source": "Nat Rev Mol Cell Biol", "type": "ref", "volume": "5", "year": "2004"}, "text": "The RAF proteins take centre stage", "sentences": [], "annotations": [], "relations": []}, {"offset": 41470, "infons": {"fpage": "1283", "pub-id_pmid": "19360305", "section_type": "REF", "source": "Oncol Rep", "type": "ref", "volume": "21", "year": "2009"}, "text": "Different types of K-Ras mutations are conversely associated wi